A
apoQlar
Health Tech & Medtech · Hamburg, Germany · Founded 2017
Powering the Future of Surgical Care & Medical Education in Mixed Reality MoreLess
apoQlar is a pioneering company in the healthcare technology sector, specializing in the development of mixed reality solutions for medical professionals. Their flagship product, VSI HoloMedicine, utilizes Microsoft HoloLens 2 hardware to convert traditional medical images and workflows into an immersive 3D mixed reality environment. This technology significantly enhances the way medical professionals practice, experience, learn, and share medical knowledge globally. The primary clients include professors, physicians, and medical institutions who benefit from reduced cognitive overload during complex procedures and improved collaborative capabilities. Operating in the global healthcare market, apoQlar's business model revolves around software licensing and service fees, generating revenue through the adoption of their innovative HoloMedicine platform. The company has been recognized as a finalist for the 2020 Microsoft Partner of the Year Awards and has won the Novartis Digital Health Award, underscoring its impact and innovation in the medical field.
Keywords: mixed reality, medical imaging, clinical workflows, medical education, HoloLens, healthcare technology, cognitive overload, collaborative medicine, software platform, global healthcare.
Company overview
apoQlar company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Hamburg, Germany
- Employees
- 51
- Open positions
- 2
- Dealroom signal
- 60.6
Valuation & funding
apoQlar funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $11M | $44M | IFB Innovationsstarter · YZR Capital | ↗ |
| EARLY VC✓Equity / VC | Jul 2023 | $0 | — | YZR Capital | ↗ |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $7.1M | 0% | 51 |
| 2025 | $7.1M | 0% | 55 |
| 2024 | $7.1M | 0% | 67 |
| 2023 | $7.1M | +331.5% | 66 |
| 2022 | $1.6M | -56.6% | 42 |
| 2021 | $3.8M | +31% | 41 |
| 2020 | $2.9M | — | 24 |
Growth signals
apoQlar website traffic
Latest recorded traffic for apoQlar is 120 monthly website visits, up 33.3% over the last three months. apoQlar's team declined 7.3% over the past year.
Hiring
Open positions at apoQlar
Current openings linked to this company in Dealroom.
Comparisons
apoQlar compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
apoQlar's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on apoQlar's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where apoQlar has talent and traffic
team presence
In the news
Latest news about apoQlar
Recent press, funding announcements, and product moves mentioning apoQlar — open to read from the original sources.
Market sentiment
What the market is saying about apoQlar
An AI-synthesized read of the highest-engagement posts about apoQlar on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See apoQlar’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.